Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'

TY - JOUR

T1 - Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'

AU - Cohen, Benjamin L.

AU - Hanauer, Stephen B.

N1 - Funding Information: Potential Competing Interests: B.L.C. participates in consulting for AbbVie, Allergan, Janssen, Target PharmaSolutions, and Sublimity Therapeutics. Z.R.G. participates in consulting for AbbVie, Janssen, Pfizer, and Takeda. C.H. participates in consulting for AbbVie, Genentech, Janssen, Pfizer, Samsung Bioepis, and Takeda. J.K.H. has received research funding from RedHill Biosciences, Janssen, AbbVie, Celgene, Genentech, Eli-Lilly, Lycera, and Pfizer Inc. and serves as a consultant for AbbVie, Janssen, and Pfizer. J.K. participates in consulting for AbbVie, Genentech, Janssen, and Pfizer. U.M. participates in consulting for AbbVie, BMS, Genentech, Gilead, Janssen, and Takeda and contracted research for Celgene and Pfizer. A.C.M. participates in consulting for Janssen and contracted research for Pfizer. L.E.R. participates in consulting for Pfizer. M.R. participates in consulting for AbbVie, Allergan, Amgen, Celgene, Genentech, Gilead, Janssen, Miraca Labs, Pfizer, Prometheus Labs, Salix, Seres, Takeda, Target PharmaSolutions, and UCB; received research support from AbbVie, Janssen, Pfizer, and Takeda; and unrestricted educational grants from AbbVie, Janssen, Pfizer, Salix, Shire, Takeda, and UCB. E.S. participates in educational speaking for Janssen. Douglas Wolf receives research funding from Takeda and UCB; serves as a speaker for AbbVie, Janssen, Pfizer, Takeda, and UCB; and participates in consulting for AbbVie, Arena, Celgene, Janssen, Lilly, Pfizer, Prometheus, Salix, Takeda, and UCB. M.C.D. participates in consulting for AbbVie, Arena, BMS, UCB, Genentech, Gilead, Janssen, Pfizer, Prometheus Labs, and Takeda. Anish Patel participates in consulting for Prometheus Labs and speaker's bureau for Daichi Dankyo, Janssen, and Takeda. S.B.H. participates in consulting for AbbVie, Allergan, Amgen, Arena, Bristol Myers Squibb, Celgene, Celltrion, Genentech, Gilead, GSK, Janssen, Lilly, Merck, Nestle, Novartis, Pfizer, Progenity, Prometheus, Receptos, Salix, Samsung Bioepis, Seres Therapeutics, Takeda, Tigenex, UCB, and VHsquared; speaking for AbbVie, Janssen, and Takeda; and data safety and monitoring board for Arena, Boehringer-Ingelheim, and Bristol Myers Squibb. ACKNOWLEDGMENTS Funding Information: This work received administrative support from the American College of Gastroenterology (Bradley C. Stillman and Maria T. Susano) and the Crohn's & Colitis Foundation. There was no funding for this work.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85090491701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090491701&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000000809

DO - 10.14309/ajg.0000000000000809

M3 - Article

C2 - 32826573

AN - SCOPUS:85090491701

SN - 0002-9270

VL - 115

SP - 1362

EP - 1366

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 9

ER -